rolly
The market has changed and snippets of news are no longer enough to fuel a constant rise in share price. Those selling off might well be looking ahead and figuring they'll have good opportunity to buy in before the P2 results. Not enough here to suggest a Pharma deal, more in line with the come back after good P2 results.
Out of interest. The IMUOA options expire November 2020. Estimated primary completion is currently August 2020, estimated study completion is December 2020. I hope the trial moves swiftly and doesn't slip.
Cheers
rollyThe market has changed and snippets of news are no longer...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
-0.001(2.56%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 3.9¢ | 3.8¢ | $134.8K | 3.498M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 1738258 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 494405 | 4 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
